Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.

OBJECTIVE: To examine the effects of interferon beta (IFNβ)-1b on all-cause mortality over 21 years in the cohort of 372 patients who participated in the pivotal randomized clinical trial (RCT), retaining (in the analysis) the original randomized treatment-assignments. METHODS: For this randomized...

全面介绍

书目详细资料
Main Authors: Goodin, D, Reder, A, Ebers, G, Cutter, G, Kremenchutzky, M, Oger, J, Langdon, D, Rametta, M, Beckmann, K, DeSimone, T, Knappertz, V
格式: Journal article
语言:English
出版: 2012